BTIG Maintains Buy on OrthoPediatrics, Raises Price Target to $29
OrthoPediatrics Corp.
OrthoPediatrics Corp. KIDS | 0.00 |
BTIG analyst Ryan Zimmerman maintains OrthoPediatrics (NASDAQ:
KIDS) with a Buy and raises the price target from $24 to $29.
